韩国痛风管理指南。
Korean guidelines for the management of gout.
机构信息
Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
出版信息
Korean J Intern Med. 2023 Sep;38(5):641-650. doi: 10.3904/kjim.2023.206. Epub 2023 Aug 28.
Abstract
Gout is the most common form of arthritis, with the prevalence increasing worldwide. The present treatment guidelines provide recommendations for the appropriate treatment of acute gout, management during the inter-critical period, and prevention of chronic complications. The guidelines were developed based on evidence-based medicine and draft recommendations finalized after expert consensus. These guidelines are designed to provide clinicians with clinical evidence to enable efficient treatment of gout.
摘要
痛风是最常见的关节炎类型，其患病率在全球范围内呈上升趋势。目前的治疗指南为急性痛风的适当治疗、缓解期的管理以及慢性并发症的预防提供了建议。这些指南是基于循证医学制定的，并在专家共识后最终确定了草案建议。这些指南旨在为临床医生提供临床证据，以实现痛风的有效治疗。
相似文献
1
Korean guidelines for the management of gout.韩国痛风管理指南。
Korean J Intern Med. 2023 Sep;38(5):641-650. doi: 10.3904/kjim.2023.206. Epub 2023 Aug 28.
2
Korean guidelines for the management of gout.韩国痛风管理指南。
J Rheum Dis. 2023 Jul 1;30(3):141-150. doi: 10.4078/jrd.2023.0029.
3
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).美国医师学院与国际风湿病学会痛风管理指南不一致：痛风、高尿酸血症及晶体相关性疾病网络（G-CAN）的共识声明。
Nat Rev Rheumatol. 2017 Sep;13(9):561-568. doi: 10.1038/nrrheum.2017.126. Epub 2017 Aug 10.
4
Gouty Arthritis: A Review of Acute Management and Prevention.痛风性关节炎：急性处理与预防综述
Pharmacotherapy. 2016 Aug;36(8):906-22. doi: 10.1002/phar.1788. Epub 2016 Jul 22.
5
Recommendations in clinical practice guidelines on gout: systematic review and consistency analysis.临床实践指南中关于痛风的推荐意见：系统评价和一致性分析。
Clin Exp Rheumatol. 2020 Sep-Oct;38(5):964-972. Epub 2020 Jan 20.
6
[European League Against Rheumatism evidence-based recommendations for diagnosis and management of gout].[欧洲抗风湿病联盟关于痛风诊断和管理的循证推荐意见]
Z Rheumatol. 2007 Nov;66(7):568-72. doi: 10.1007/s00393-007-0209-x.
7
[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].[专科领域痛风性关节炎诊断与治疗的循证推荐：德国风湿病学会与德国医学专业协会共同发布的S2e指南]
Z Rheumatol. 2017 Mar;76(2):118-124. doi: 10.1007/s00393-016-0249-1.
8
Current state and prospects of gout treatment in Korea.韩国痛风治疗的现状与展望。
Korean J Intern Med. 2022 Jul;37(4):719-731. doi: 10.3904/kjim.2022.036. Epub 2022 Jun 3.
9
Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.痛风与高尿酸血症的管理：台湾地区的多学科共识
Int J Rheum Dis. 2018 Apr;21(4):772-787. doi: 10.1111/1756-185X.13266. Epub 2018 Jan 24.
10
Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population.韩国人群痛风性关节炎中ABCG2和SLC2A9基因多态性的遗传分析
Korean J Intern Med. 2015 Nov;30(6):913-20. doi: 10.3904/kjim.2015.30.6.913. Epub 2015 Oct 30.
引用本文的文献
1
Gouty arthritis patients' diagnostic, biochemical, and hematological characteristics study: a single-center retrospective study.痛风性关节炎患者的诊断、生化及血液学特征研究：一项单中心回顾性研究。
BMC Musculoskelet Disord. 2024 Dec 20;25(1):1054. doi: 10.1186/s12891-024-08151-0.
本文引用的文献
1
Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence.患者对痛风和痛风管理的观点和偏好：对依从性的影响。
J Korean Med Sci. 2021 Aug 16;36(32):e208. doi: 10.3346/jkms.2021.36.e208.
2
Evaluation of febuxostat initiation during an acute gout attack: A prospective, randomized clinical trial.评价急性痛风发作时使用非布司他进行治疗：一项前瞻性、随机临床试验。
Joint Bone Spine. 2020 Oct;87(5):461-466. doi: 10.1016/j.jbspin.2020.03.017. Epub 2020 Apr 14.
3
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.在初级保健中比较萘普生和小剂量秋水仙碱治疗痛风发作的开放性标签随机实用试验（CONTACT）。
Ann Rheum Dis. 2020 Feb;79(2):276-284. doi: 10.1136/annrheumdis-2019-216154. Epub 2019 Oct 30.
4
Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.别嘌醇剂量递增对痛风患者骨侵蚀和尿酸盐容积的影响：一项随机对照试验中的双能 CT 成像研究。
Arthritis Rheumatol. 2019 Oct;71(10):1739-1746. doi: 10.1002/art.40929. Epub 2019 Aug 12.
5
Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.降尿酸治疗停药的影响：系统评价。
J Gen Intern Med. 2018 Mar;33(3):358-366. doi: 10.1007/s11606-017-4233-5. Epub 2017 Dec 4.
6
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.逐步增加非布司他的剂量与秋水仙碱预防降尿酸治疗初始阶段痛风发作的疗效相当：来自前瞻性、多中心随机研究 FORTUNE-1 的结果。
Ann Rheum Dis. 2018 Feb;77(2):270-276. doi: 10.1136/annrheumdis-2017-211574. Epub 2017 Nov 4.
7
Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis.非布司他与别嘌醇对高尿酸血症患者肾脏保护作用的比较：一项系统评价和荟萃分析。
Kidney Res Clin Pract. 2017 Sep;36(3):274-281. doi: 10.23876/j.krcp.2017.36.3.274. Epub 2017 Sep 30.
8
Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.血脂异常、饮酒和肥胖是与接受降尿酸治疗的患者尿酸水平控制不佳相关的主要因素。
Arthritis Care Res (Hoboken). 2018 Jun;70(6):918-924. doi: 10.1002/acr.23347. Epub 2018 Mar 23.
9
Corticosteroid or Nonsteroidal Antiinflammatory Drugs for the Treatment of Acute Gout: A Systematic Review of Randomized Controlled Trials.皮质类固醇或非甾体抗炎药治疗急性痛风：随机对照试验的系统评价。
J Rheumatol. 2018 Jan;45(1):128-136. doi: 10.3899/jrheum.170137. Epub 2017 Aug 1.
10
The British Society for Rheumatology Guideline for the Management of Gout.英国风湿病学会痛风管理指南
Rheumatology (Oxford). 2017 Jul 1;56(7):e1-e20. doi: 10.1093/rheumatology/kex156.
Zotero 插件